• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT SRL ALINIQ AMS; CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT SRL ALINIQ AMS; CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE Back to Search Results
Catalog Number 03R89-63
Medical Device Problem Code Computer Software Problem (1112)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/23/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
All available patient information was included.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event or Problem Description
The customer reported incorrect aliniq ams software version 3.01 configuration and provided the following information: customer stated that there have been occasions where elements of sigma strong assays have not been completed correctly.More specifically, the impacted sigma strong assays have not been implemented with linear ranges.The customer reported that this has been associated with several incidents linked to patient samples being reported late and/or incorrectly, however the was no reported impact to patient management.The customer reported that abbott personnel performed the aliniq ams configuration implementation and that the assay performance with the instrument is within expectations based on verification.There was no reported impact to patient management.
 
Event or Problem Description
The customer reported incorrect aliniq ams software version 3.01 configuration and provided the following information: customer stated that there have been occasions where elements of sigma strong assays have not been completed correctly.More specifically, the impacted sigma strong assays have not been implemented with linear ranges.The customer reported that this has been associated with several incidents linked to patient samples being reported late and/or incorrectly, however the was no reported impact to patient management.The customer reported that abbott personnel performed the aliniq ams configuration implementation and that the assay performance with the instrument is within expectations based on verification.There was no reported impact to patient management.
 
Additional Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, and device history record review.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.Ticket search and trending did not find any additional complaints similar to the customer reported issue.Device history review did not identify any nonconformances or potential nonconformances related to the customer reported issue.Labeling was reviewed and was found to address the customer reported issue.The customer reported assays were not completed correctly in aliniq ams.The investigation found that partial information was provided and confirmed the reported issue was a result of assays not being configured correctly in aliniq ams.The customer was provided with a checklist of the parameters to be reviewed for implementation into aliniq ams.Based on the available information within the complaint, the aliniq ams contained an incorrect configuration.Based on the investigation, no systemic issue or deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINIQ AMS
Common Device Name
CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE
Manufacturer (Section D)
ABBOTT SRL
via giorgio ribotta 9
rome 00144
IT  00144
Manufacturer (Section G)
ABBOTT SRL
via giorgio ribotta 9
rome 00144
IT   00144
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key18377640
Report Number3004032053-2023-00031
Device Sequence Number7711030
Product Code JQP
UDI-Device Identifier00380740202736
UDI-Public(01)00380740202736(10)3.02
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 04/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number03R89-63
Device Lot NumberOCN01128
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/29/2023
Supplement Date Received by Manufacturer04/10/2024
Initial Report FDA Received Date12/21/2023
Supplement Report FDA Received Date04/16/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/27/2022
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-